Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectivity and Toxicity of Apatinib for Unresectable Advanced Chondrosarcoma: a Multicentric Retrospective Study

NCT04260113 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04260113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectivity and Toxicity of Apatinib for Unresectable Advanced Chondrosarcoma: a Multicentric Retrospective Study
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2019
Completion date
April 1, 2020
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, toxicity, drug